MarginsXMarginsX
Home › Markets › Health Care › NUS

Nu Skin Enterprises Inc. (NUS)

NUS trades on NYSE in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.93
-2.48% on the day
Market cap
$191.3M
Micro cap
Revenue · 2025
$1.5B
-14.3% on 2024
Net income · 2025
$160.2M
10.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1021561/000114036126005130/0001140361-26-005130-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerNUS on NYSE
SectorHealth Care
IndustryOther Pharmaceuticals
CountryUnited States
IPO year1996
SEC CIK0001021561
SEC industry codeWholesale-Drugs, Proprietaries & Druggists' Sundries
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.5B
Net income$160.2M
Operating income$65.8M
Net margin10.8%
Operating margin4.4%
Revenue growth-14.3%
Cash$238.6M
Total assets$1.4B
P/E (computed)1.2×
P/S (computed)0.1×

Warning signs

Cash runway
Cash-flow positive
$164.9M cash at September 30, 2026
Share count, 1 year
-0.1%
2025-11-01 to 2026-10-31 · -1.5% over 3 years
Going-concern doubt
No
10-Q filed November 6, 2026
Insider net buying, 12 months
-$47K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-06
Cash and burn$164.9M cash; operating cash flow $3.8M a quarter.Report 2026-09-30
Shares outstanding48,678,057 (2026-10-31); 48,750,076 a year earlier; 49,409,268 three years earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Salt Lake City, Utah, United StatesPCAOB Form AP 2026-03-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $53K, sold $100K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$311.0M-$742K-$8.1M$164.9M$203.7M$1.3B10-Q 2026-11-06
Q2 2026
2026-06-30
$320.1M-$249.8M$10.6M$189.6M$213.7M$1.4B10-Q 2026-08-10
Q1 2026
2026-03-31
$320.6M$1.8M-$3.9M$198.7M$223.6M$1.4B10-Q 2026-05-08
Q4 2025
2025-12-31
$370.3M$14.5M$16.6M$238.6M$224.2M$1.5B10-K 2026-02-13
Q3 2025
2025-09-30
$364.2M$17.1M$27.5M$251.8M$229.0M$1.6B10-Q 2026-11-06
Q2 2025
2025-06-30
$386.1M$21.1M$35.8M$264.2M$248.9M$1.6B10-Q 2026-08-10
Q1 2025
2025-03-31
$364.5M$107.5M$389K$203.8M$238.8M$1.7B10-Q 2026-05-08
Q4 2024
2024-12-31
$445.6M-$36.1M$25.8M$186.9M$393.6M$1.7B10-K 2026-02-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-3ASR
S-3ASR2018-03-01
Latest annual report
FORM 10-K
10-K2026-02-13
Latest quarterly / interim10-Q2026-11-06
Latest current report
FORM 8-K
8-K2026-11-05
Latest proxy
2026 NOTICE OF INTERNET AVAILABILITY
DEFA14A2026-04-03

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.7%
1 month-19.6%
3 months-16.9%
Year to date-58.1%
1 year-58.8%
From 52-week high-65.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Other Pharmaceuticals

TickerCompanyPriceDayMarket cap
COSMCosmos Health Inc.$2.49-23.15%$250.6M
ZSTKZeroStack Corp.$2.80-1.75%$61.1M
ESYNEnerSyn Global Inc.$1.250.00%$37.2M
HLFHerbalife Ltd. Common Shares$16.15+1.19%$1.7B
HKPDCellyan Biotechnology Co. Ltd$1.61-0.62%$4.0M
MEDSDataMeds AI Inc.$0.6421-13.68%$3.1M
CAHCardinal Health Inc.$283.85+0.98%$65.6B
CORCencora Inc.$356.94-0.58%$68.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier